Target intelligence / Profile preview

Zinc transporter (Solute carrier family 30 and 39) (ZnT/ZIP)

Target
ZnT/ZIP
Molecular classification
Transporter, Solute carrier family
01

Overview

Intracellular zinc transport refers to the regulated movement of zinc ions across biological membranes, a process primarily executed by two major protein families: the SLC30 (ZnT) family and the SLC39 (ZIP) family [PubMed: 25310994]. The ZnT transporters function to decrease cytosolic zinc levels by exporting ions into the extracellular space or sequestering them within intracellular organelles, such as the Golgi apparatus or zincosomes [UniProt]. Conversely, ZIP transporters increase cytosolic zinc concentrations by facilitating the influx of zinc from the extracellular environment or its release from internal stores [PubMed: 25310994]. Zinc is an essential trace element that serves as a cofactor for over 3,000 proteins, making its transport vital for cellular processes including DNA synthesis, immune response, and apoptosis [NIH]. Dysregulation of these transport mechanisms is implicated in various diseases, such as Type 2 diabetes (associated with ZnT8 variants), acrodermatitis enteropathica (caused by ZIP4 mutations), and several cancers where ZIP transporters are often upregulated to support rapid cell proliferation [PubMed: 17314970, 18070915]. Pharmacological strategies targeting this system include the use of zinc ionophores like PBT2 to redistribute zinc in neurodegenerative diseases or specific transporter inhibitors to combat malignancy [PubMed: 25310994].

Other names
Zinc transport systemSLC30 familySLC39 familyZIP transportersZnT transportersZinc ion transport
02

Mechanism of action

Modulation of zinc ion flux across cellular and organellar membranes to maintain or restore physiological zinc concentrations [PubMed: 25310994].

03

Biological functions

Zinc homeostasisSignal transductionCell proliferationApoptosisImmune responseEnzyme regulation
04

Disease associations

Type 2 diabetesCancer (Pancreatic, Hepatocellular, Prostate)Alzheimer's diseaseAcrodermatitis enteropathicaInflammation
05

Safety considerations

Copper deficiency (due to competitive absorption)Gastrointestinal irritationNeurotoxicity from excessive zinc accumulationGenotoxicity at supra-physiological levels
06

Interacting drugs

Zinc gluconate

4 more in the full profile.

07

Biomarkers

ZnT8 autoantibodies (ZNT8A)Serum zinc levelsZIP4 expression levelsIntracellular labile zinc concentration

Beyond the preview

Go deeper on Zinc transporter (Solute carrier family 30 and 39) (ZnT/ZIP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc transporter (Solute carrier family 30 and 39) (ZnT/ZIP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call